Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Parasitic Diseases Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Parasitic Diseases Therapeuticmarket, defines the market attractiveness level of Parasitic Diseases Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Parasitic Diseases Therapeutic industry, describes the types of Parasitic Diseases Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Parasitic Diseases Therapeutic market and the development prospects and opportunities of Parasitic Diseases Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Parasitic Diseases Therapeutic market in Chapter 13.
By Player:
Bayer
Pfizer
F Hoffmann-La Roche
GlaxoSmithKline
Sanaria
By Type:
Peptides Medicine
Insect Repellent
Acaricide
Other
By End-User:
Commercial
Household
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Parasitic Diseases Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Parasitic Diseases Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Parasitic Diseases Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Parasitic Diseases Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Parasitic Diseases Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Parasitic Diseases Therapeutic Consumption (2017-2022)
-
7.2 United States Parasitic Diseases Therapeutic Consumption (2017-2022)
-
7.3 Europe Parasitic Diseases Therapeutic Consumption (2017-2022)
-
7.4 China Parasitic Diseases Therapeutic Consumption (2017-2022)
-
7.5 Japan Parasitic Diseases Therapeutic Consumption (2017-2022)
-
7.6 India Parasitic Diseases Therapeutic Consumption (2017-2022)
-
7.7 South Korea Parasitic Diseases Therapeutic Consumption (2017-2022)
8 Region and Country-wise Parasitic Diseases Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Parasitic Diseases Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Parasitic Diseases Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Parasitic Diseases Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Parasitic Diseases Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Parasitic Diseases Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Parasitic Diseases Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Parasitic Diseases Therapeutic Consumption Forecast (2022-2028)
9 Global Parasitic Diseases Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Parasitic Diseases Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Peptides Medicine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Insect Repellent Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Acaricide Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Parasitic Diseases Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Commercial Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Household Consumption and Growth Rate (2017-2022)
10 Global Parasitic Diseases Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Peptides Medicine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Insect Repellent Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Acaricide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Commercial Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Household Consumption Forecast and Growth Rate (2022-2028)
11 Global Parasitic Diseases Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Parasitic Diseases Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Parasitic Diseases Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Parasitic Diseases Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Parasitic Diseases Therapeutic Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Parasitic Diseases Therapeutic Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Parasitic Diseases Therapeutic Product and Service
-
14.3 F Hoffmann-La Roche
-
14.3.1 F Hoffmann-La Roche Company Details
-
14.3.2 F Hoffmann-La Roche Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 F Hoffmann-La Roche Parasitic Diseases Therapeutic Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Parasitic Diseases Therapeutic Product and Service
-
14.5 Sanaria
-
14.5.1 Sanaria Company Details
-
14.5.2 Sanaria Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanaria Parasitic Diseases Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Parasitic Diseases Therapeutic
-
Figure Parasitic Diseases Therapeutic Picture
-
Table Global Parasitic Diseases Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parasitic Diseases Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parasitic Diseases Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Parasitic Diseases Therapeutic Consumption by Country (2017-2022)
-
Figure United States Parasitic Diseases Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Parasitic Diseases Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Parasitic Diseases Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Parasitic Diseases Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Parasitic Diseases Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Parasitic Diseases Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Parasitic Diseases Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Parasitic Diseases Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptides Medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Insect Repellent Consumption and Growth Rate (2017-2022)
-
Figure Global Acaricide Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Commercial Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Peptides Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insect Repellent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acaricide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Commercial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Parasitic Diseases Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Parasitic Diseases Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Parasitic Diseases Therapeutic Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Parasitic Diseases Therapeutic Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Parasitic Diseases Therapeutic Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Parasitic Diseases Therapeutic Product and Service
-
Table Sanaria (Foundation Year, Company Profile and etc.)
-
Table Sanaria Parasitic Diseases Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanaria Parasitic Diseases Therapeutic Product and Service
-
